Jiro Nakayama
Papers
1
Total Citations
4
H-Index
1
About
Jiro Nakayama is a leading researcher in the intersection of oncology and musculoskeletal health, with a primary focus on the skeletal complications of cancer therapies. His most cited work, a 2024 study published in a high-impact journal, rigorously examines the impact of androgen deprivation therapy (ADT) on lumbar spine bone health in prostate cancer patients. Using quantitative computed tomography in a carefully propensity-matched cohort, Nakayama provided precise, volumetric evidence of bone mineral density loss, directly addressing the critical clinical issue of fragility fracture risk. This contribution has already garnered 4 citations, signaling its immediate relevance to urologists, oncologists, and radiologists. Beyond this landmark study, Nakayama’s research portfolio spans the broader domains of cancer treatment-induced bone loss, advanced imaging biomarkers, and personalized risk stratification. His work is distinguished by its methodological rigor—employing state-of-the-art imaging and robust statistical matching to isolate treatment effects. For students and researchers, Nakayama exemplifies how translational imaging research can directly inform clinical decision-making, offering a model for investigating long-term toxicities of life-saving therapies.
Research Focus
Key Achievements
Top Papers
- 1